SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-023629
Filing Date
2020-11-12
Accepted
2020-11-12 16:17:09
Documents
51
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inbp20200930_10q.htm 10-Q 699765
2 EXHIBIT 31.1 CERTIFICATION OF CO-CEOS ex_213161.htm EX-31.1 13551
3 EXHIBIT 31.2 CERTIFICATION OF CFO ex_213162.htm EX-31.2 15591
4 EXHIBIT 32.1 CERTIFICATION OF PERIODIC REPORT CO-CEOS ex_213163.htm EX-32.1 9508
5 EXHIBIT 32.2 CERTIFICATION OF PERIODIC REPORT CFO ex_213164.htm EX-32.2 7360
  Complete submission text file 0001437749-20-023629.txt   3928058

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT inbp-20200930.xml EX-101.INS 811480
7 XBRL TAXONOMY EXTENSION SCHEMA inbp-20200930.xsd EX-101.SCH 43486
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20200930_cal.xml EX-101.CAL 44139
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20200930_def.xml EX-101.DEF 268468
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20200930_lab.xml EX-101.LAB 243338
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20200930_pre.xml EX-101.PRE 286572
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 201306928
SIC: 2834 Pharmaceutical Preparations